Drug Type ASO |
Synonyms FYNM 006, FYNM006 |
Target |
Mechanism ATXN3 gene modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebellar Ataxia | Preclinical | CN | 01 Oct 2024 |